Endoscopic Retrograde Cholangiopancreatography Ercp Devices Market
Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Forecasts to 2030 - Global Analysis by Product (Endotherapy Devices, Endoscopes, Imaging Devices, Sphincterotomes, Stents and Other Products), Type, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market is accounted for $1628.6 million in 2024 and is expected to reach $2627.7 million by 2030 growing at a CAGR of 8.3% during the forecast period. Endoscopic Retrograde Cholangiopancreatography (ERCP) devices are specialist medical equipment used to perform diagnostic and therapeutic treatments on the bile and pancreatic channels. Endoscopy and fluoroscopy are combined in ERCP to view and treat malignancies, strictures, and bile duct stones. A flexible endoscope is inserted through the mouth into the duodenum during the surgery. There, specialized tools such as biopsy forceps, dilators, stents, and catheters are used to clear blockages, put stents, or take tissue samples. Because they provide highly accurate, minimally invasive solutions, ERCP devices are essential for the diagnosis and treatment of pancreatic and biliary disorders.
According to the National Cancer Database, 68.5% of pancreatic cancer diagnoses in the United States are made in people over 65 years old.
Market Dynamics:
Driver:
Increasing Prevalence of Biliary and Pancreatic Disorders
The growing prevalence of biliary and pancreatic illnesses, such as gallstones, bile duct strictures, and pancreatitis, pushes up demand for Endoscopic Retrograde Cholangiopancreatography (ERCP) equipment. Effective management of these disorders depends on precise diagnosis and treatment, which makes ERCP procedures crucial. The growing number of instances, especially in older populations, encourages the use of ERCP devices and propels market expansion. The market is further expanded by ERCP's minimally invasive treatments and early identification, which enhance patient outcomes.
Restraint:
High Cost of ERCP Procedures and Devices
The high cost of ERCP procedures and equipment stifles market expansion, especially in low- and middle-income countries with restricted healthcare resources. The necessity for specialist personnel, high equipment costs, and procedural expenses may discourage hospitals and clinics from implementing ERCP technology. Further impeding the broad adoption of ERCP devices despite their therapeutic benefits are insurance coverage and payment issues, which can limit patient access to these cutting-edge procedures.
Opportunity:
Advancements in Minimally Invasive Procedures
Advances in minimally invasive techniques have a substantial impact on the ERCP device market by improving treatment precision and safety. Improved endoscopic imaging, more compact and flexible devices, and sophisticated biopsy instruments are examples of innovations that allow for better therapy results and diagnostics while shortening recuperation periods for patients. ERCP devices are becoming more and more in demand as patients choose less intrusive alternatives to standard surgery. These developments also increase treatment options, decrease problems, and streamline procedures, which support the market's growth.
Threat:
Risk of Complications
The risk of complications, such as pancreatitis, bleeding, or infections, prevents widespread use of ERCP devices. Particularly in high-risk situations, these possible hazards can discourage patients from choosing ERCP procedures and medical professionals from endorsing them. Additionally, as not all facilities may be prepared to carry out such sophisticated procedures safely; the requirement for highly qualified experts to reduce difficulties can raise costs and hinder market expansion.
Covid-19 Impact:
The COVID-19 pandemic significantly impacted the Endoscopic Retrograde Cholangiopancreatography (ERCP) devices market, leading to delays and cancellations of elective procedures due to healthcare system strain. This resulted in reduced demand for ERCP devices. However, as healthcare systems recover, the market is expected to rebound with increased focus on minimally invasive diagnostic and therapeutic procedures, particularly for gastrointestinal and biliary disorders.
The biopsy forceps segment is expected to be the largest during the forecast period
The biopsy forceps segment is expected to be the largest during the forecast period because there is a growing need for precise diagnostic techniques for pancreatic and biliary disorders. During ERCP, biopsy forceps make it possible to take tissue samples, which aids in the early diagnosis of strictures, cancer, and other anomalies. The use of biopsy forceps is increased by the growing incidence of gastrointestinal disorders and improvements in minimally invasive procedures. Improved safety and accuracy are two more design elements that support market expansion.
The dilators segment is expected to have the highest CAGR during the forecast period
The dilators segment is expected to have the highest CAGR during the forecast period owing to the rising prevalence of biliary problems, advances in minimally invasive surgical techniques, and the increased desire for precise and effective procedures. In order to ensure smoother endoscope transit, dilators are necessary to dilate the strictures in the pancreatic and bile ducts. The market for ERCP devices is expanding as a result of technological advancements such disposable, ergonomic designs, and enhanced safety features that encourage the use of dilators.
Region with largest share:
North America is anticipated to hold the largest market share during the forecast period because biliary tract conditions like pancreatitis, cholangiocarcinoma, and gallstones are becoming more common. Treatment accuracy and patient outcomes are being improved by technological developments in ERCP devices, including as enhanced imaging systems and minimally invasive treatments. Furthermore, the region's high healthcare spending, well-established healthcare infrastructure, and rising use of cutting-edge medical technology all support the rising demand for ERCP devices, which in turn propels the market's expansion.
Region with highest CAGR:
Asia Pacific is anticipated to witness the highest CAGR over the forecast period due to increasing healthcare infrastructure, rising incidences of biliary and pancreatic diseases, and a growing aging population. Advancements in ERCP technologies, such as improved imaging and minimally invasive techniques, are enhancing diagnostic and therapeutic capabilities. Additionally, the region's expanding healthcare access, rising medical tourism and adoption of advanced medical devices are boosting the demand for ERCP devices, fueling market growth in Asia Pacific.
Key players in the market
Some of the key players in Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market include AMBU, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, Cook Group, FUJIFILM Holdings Corporation, Hobbs Medical, Inc., HOYA Group, Karl Storz SE & Co. KG, Medi-Globe GmbH, Medline Industries, Inc., Medtronic PLC, Olympus Corporation, Streis PLC, Stryker Corporation, Taewoong Medical Co., Ltd. and Telemed System, Inc.
Key Developments:
In September 2024, Medtronic expanded AiBLE spine surgery ecosystem with new technologies and Siemens Healthineers partnership.
In April 2024, Medtronic plc announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system, along with a strategic collaboration designed to enhance patient care.
In December 2023, Medtronic plc announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, to offer continued innovation and scalable healthcare advancements for patients and caregivers globally.
Products Covered:
• Endotherapy Devices
• Endoscopes
• Imaging Devices
• Sphincterotomes
• Stents
• Balloon Catheters
• Biopsy Forceps
• Guidewires
• Dilators
• Other Products
Types Covered:
• Conventional ERCP
• Single-Operator ERCP
• Laparoscopic ERCP
• Endoscopic Ultrasound (EUS)-Guided ERCP
• Other Types
Technologies Covered:
• Advanced Imaging Systems
• Robotic-Assisted ERCP
• Integration with AI and Machine Learning
• Other Technologies
Applications Covered:
• Diagnostic ERCP
• Therapeutic ERCP
• Other Applications
End Users Covered:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Research and Academic Institutions
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Product
5.1 Introduction
5.2 Endotherapy Devices
5.3 Endoscopes
5.4 Imaging Devices
5.5 Sphincterotomes
5.6 Stents
5.7 Balloon Catheters
5.8 Biopsy Forceps
5.9 Guidewires
5.10 Dilators
5.11 Other Products
6 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Type
6.1 Introduction
6.2 Conventional ERCP
6.3 Single-Operator ERCP
6.4 Laparoscopic ERCP
6.5 Endoscopic Ultrasound (EUS)-Guided ERCP
6.6 Other Types
7 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Technology
7.1 Introduction
7.2 Advanced Imaging Systems
7.3 Robotic-Assisted ERCP
7.4 Integration with AI and Machine Learning
7.5 Other Technologies
8 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Application
8.1 Introduction
8.2 Diagnostic ERCP
8.2.1 Cholangiocarcinoma
8.2.2 Pancreatitis
8.2.3 Gallstones
8.2.4 Biliary Strictures
8.3 Therapeutic ERCP
8.3.1 Stone Extraction
8.3.2 Stent Placement
8.3.3 Sphincterotomy
8.3.4 Dilation of Strictures
8.3.5 Drainage of Infected Bile
8.4 Other Applications
9 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Specialty Clinics
9.4 Ambulatory Surgical Centers
9.5 Research and Academic Institutions
9.6 Other End Users
10 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 AMBU, Inc.
12.2 B. Braun Melsungen AG
12.3 Boston Scientific Corporation
12.4 CONMED Corporation
12.5 Cook Group
12.6 FUJIFILM Holdings Corporation
12.7 Hobbs Medical, Inc.
12.8 HOYA Group
12.9 Karl Storz SE & Co. KG
12.10 Medi-Globe GmbH
12.11 Medline Industries, Inc.
12.12 Medtronic PLC
12.13 Olympus Corporation
12.14 Streis PLC
12.15 Stryker Corporation
12.16 Taewoong Medical Co., Ltd.
12.17 Telemed System, Inc.
List of Tables
1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Region (2022-2030) ($MN)
2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Product (2022-2030) ($MN)
3 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Endotherapy Devices (2022-2030) ($MN)
4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Endoscopes (2022-2030) ($MN)
5 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Imaging Devices (2022-2030) ($MN)
6 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Sphincterotomes (2022-2030) ($MN)
7 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Stents (2022-2030) ($MN)
8 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Balloon Catheters (2022-2030) ($MN)
9 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Biopsy Forceps (2022-2030) ($MN)
10 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Guidewires (2022-2030) ($MN)
11 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Dilators (2022-2030) ($MN)
12 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other Products (2022-2030) ($MN)
13 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Type (2022-2030) ($MN)
14 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Conventional ERCP (2022-2030) ($MN)
15 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Single-Operator ERCP (2022-2030) ($MN)
16 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Laparoscopic ERCP (2022-2030) ($MN)
17 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Endoscopic Ultrasound (EUS)-Guided ERCP (2022-2030) ($MN)
18 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other Types (2022-2030) ($MN)
19 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Technology (2022-2030) ($MN)
20 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Advanced Imaging Systems (2022-2030) ($MN)
21 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Robotic-Assisted ERCP (2022-2030) ($MN)
22 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Integration with AI and Machine Learning (2022-2030) ($MN)
23 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other Technologies (2022-2030) ($MN)
24 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Application (2022-2030) ($MN)
25 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Diagnostic ERCP (2022-2030) ($MN)
26 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Cholangiocarcinoma (2022-2030) ($MN)
27 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Pancreatitis (2022-2030) ($MN)
28 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Gallstones (2022-2030) ($MN)
29 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Biliary Strictures (2022-2030) ($MN)
30 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Therapeutic ERCP (2022-2030) ($MN)
31 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Stone Extraction (2022-2030) ($MN)
32 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Stent Placement (2022-2030) ($MN)
33 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Sphincterotomy (2022-2030) ($MN)
34 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Dilation of Strictures (2022-2030) ($MN)
35 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Drainage of Infected Bile (2022-2030) ($MN)
36 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other Applications (2022-2030) ($MN)
37 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By End User (2022-2030) ($MN)
38 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Hospitals (2022-2030) ($MN)
39 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Specialty Clinics (2022-2030) ($MN)
40 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
41 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Research and Academic Institutions (2022-2030) ($MN)
42 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
